Numeta Ped G16% E
Numeta Ped G16% E is a medicine authorised by Swissmedic under authorisation number 61425. The authorisation holder is Baxter AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 January 2012 and the authorisation is valid without a time limit. ATC code B05BA10 places the medicine in the group Blood substitutes and perfusion solutions.
| Authorisation number | 61425 |
|---|---|
| Name | Numeta Ped G16% E |
| Full name | Numeta Ped G16% E, Infusionslösung zur totalen parenteralen Ernährung |
| Authorisation holder | Baxter AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B05BA10 |
| First authorisation | 18 January 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Numeta Ped G16% E, Infusionslösung zur totalen parenteralen Ernährung | B | 18 January 2012 |
| 2 | Numeta Ped G19% E, Infusionslösung zur totalen parenteralen Ernährung | B | 18 January 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 6 x 500 | ml | B05BA10 | 07.01.2. | B |
| 2 | 6 x 1000 | ml | B05BA10 | 07.01.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Numeta Ped G16% E authorised in Switzerland?
Yes. Numeta Ped G16% E is authorised by Swissmedic under authorisation number 61425, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Numeta Ped G16% E have?
Numeta Ped G16% E is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Numeta Ped G16% E?
The authorisation holder is Baxter AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.